Recombinant TGM2 (Zampilimab Biosimilar) antibody

Catalog No. ABIN7538079

The Humanized Chimeric anti-TGM2 (Zampilimab Biosimilar) antibody is suitable to detect TGM2 (Zampilimab Biosimilar) in samples from Human. It has been validated for ELISA and WB.

Quick Overview for Recombinant TGM2 (Zampilimab Biosimilar) antibody (ABIN7538079)

Target: TGM2 (Zampilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This TGM2 (Zampilimab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-TGM2 (Zampilimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Zampilimab Biosimilar - Anti-TGM2 mAb - Research Grade

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG4

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for TGM2 (Zampilimab Biosimilar)

Target: TGM2 (Zampilimab Biosimilar)

Target Type: Biosimilar

Background: Zampilimab is a monoclonal antibody against transglutaminase 2 (TG2). Zampilimab has potential application in renal transplant.

CAS-No: 2098280-42-1